(Q39928331)

15 September 2017

title

Hepatitis B virus core protein inhibits TRAIL-induced apoptosis of hepatocytes by blocking DR5 expression (English)

1 reference

15 September 2017

1 reference

1 reference

J Du

1

1 reference

15 September 2017

X Liang

2

1 reference

15 September 2017

Y Liu

3

1 reference

15 September 2017

Z Qu

4

1 reference

15 September 2017

L Gao

5

1 reference

15 September 2017

L Han

6

1 reference

15 September 2017

S Liu

7

1 reference

15 September 2017

M Cui

8

1 reference

15 September 2017

Y Shi

9

1 reference

15 September 2017

Z Zhang

10

1 reference

15 September 2017

L Yu

11

1 reference

15 September 2017

L Cao

12

1 reference

15 September 2017

C Ma

13

1 reference

15 September 2017

L Zhang

14

1 reference

15 September 2017

Y Chen

15

1 reference

15 September 2017

W Sun

16

1 reference

15 September 2017

publication date

17 October 2008

1 reference

Cell Death & Differentiation

15 September 2017

published in

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

219-229

1 reference

https://scigraph.springernature.com/pub.10.1038/cdd.2008.144

15 September 2017

exact match

0 references

cites work

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

A new hypothesis of pathogenetic mechanism of viral hepatitis B and C

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

The hepatitis B virus protein MHBs(t) sensitizes hepatoma cells to TRAIL-induced apoptosis through ERK2.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Characterization of two receptors for TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2008.144

7 January 2021

Identifiers

DOI

10.1038/CDD.2008.144

1 reference

15 September 2017

1 reference